TY - JOUR
T1 - Post locoregional therapy treatment imaging in hepatocellular carcinoma patients
T2 - A literature-based review
AU - Young, Shamar
AU - Taylor, Andrew J.
AU - Sanghvi, Tina
N1 - Publisher Copyright:
© 2018 Authors.
PY - 2018
Y1 - 2018
N2 - Imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as well as in determining treatment efficacy, or complications, following therapy. Unlike other cancers, HCC is most commonly treated by locoregional therapies (LRTs) such as thermal ablation, transarterial chemoembolization, and transarterial radioembolization. These treatments can lead to changes on imaging that make determination of residual/ recurrent disease difficult. This literature-based review dis-cusses the expected postimaging findings following LRT.
AB - Imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as well as in determining treatment efficacy, or complications, following therapy. Unlike other cancers, HCC is most commonly treated by locoregional therapies (LRTs) such as thermal ablation, transarterial chemoembolization, and transarterial radioembolization. These treatments can lead to changes on imaging that make determination of residual/ recurrent disease difficult. This literature-based review dis-cusses the expected postimaging findings following LRT.
KW - Hepatocellular carcinoma (HCC)
KW - Magnetic resonance imaging (MRI)
KW - Thermal ablation
KW - Transarterial chemoembolization (TACE)
KW - Transarterial radioembolization (TARE)
UR - http://www.scopus.com/inward/record.url?scp=85075482832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075482832&partnerID=8YFLogxK
U2 - 10.14218/JCTH.2017.00059
DO - 10.14218/JCTH.2017.00059
M3 - Review article
AN - SCOPUS:85075482832
SN - 2225-0719
VL - 6
SP - 189
EP - 197
JO - Journal of Clinical and Translational Hepatology
JF - Journal of Clinical and Translational Hepatology
IS - 2
ER -
